FDA User Fee Liberation Likely Hinges On Senate Appropriations Panel
This article was originally published in The Tan Sheet
Executive Summary
House leadership plans a comprehensive bill to undo sequestration for the government as a whole, but Republican Robert Aderholt, who chairs the House subcommittee that originates appropriations for FDA, says he is willing to work with Senate appropriators in conference on a fix specific to the agency’s user fees.
You may also be interested in...
FDA’s 8.2% Solution: Sequestration Would Cut $319 Million
The estimated reduction, included in the White House Office of Management and Budget’s report to Congress, is equal the cost of 900 to 1,200 agency employees, an agency advocate said.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.